Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Interim Management Statement

10 Nov 2014 07:00

RNS Number : 5259W
Kingspan Group PLC
10 November 2014
 

Kingspan Group Plc

Interim Management Statement

 

10 November 2014

 

Kingspan Group plc, the global leader in high performance insulation and building envelopes, today issues the following Interim Management Statement, with trading information for the period from 1 July to 30 September 2014.

 

Sales in the nine month period to 30 September were €1.39bn, up 5% on the prior year (+5% constant currency). A solid sales performance was also recorded in the third quarter with revenue up 7% (+5% constant currency) compared to the same period in 2013.

Insulated Panels revenue in the first nine months increased by 9% (+9% constant currency), and by 8% (+7% constant currency) in the third quarter. The UK continued to perform well with encouraging activity across most building segments. After a sluggish second quarter sales performance, Mainland Europe remained weak through the third quarter reflecting somewhat of an abatement in German market activity. The pace of sales growth in North America improved in the third quarter helped by a strong order book as we entered the second half. Order intake also showed a significant improvement over prior year. Activity in Australasia continued the strong trend evident in the first half.

Insulation Board revenue in the first nine months was up 3% (+1% constant currency) compared with the same period last year, and ahead by 6% in quarter three (+2% constant currency). The UK sales performance was positive through the third quarter, and Mainland European sales were relatively stable overall year on year. Further progress in market conversion was evident in Australia during the third quarter.

Environmental revenue in the first nine months was ahead of last year by 1% (-2% constant currency) and by 3% (-3% constant currency) in the third quarter, continuing on the path of relative stabilisation seen earlier in the year.

Access Floors revenue in the first nine months was 4% behind the same period last year (-4% constant currency). Sales in the third quarter were ahead by 11% (+8% constant currency) with continuing momentum evident in UK office construction activity and an improvement in the US relative to a weak first half.

 Net debt at the end of September 2014 was €107.7m, €39.1m lower than at the same point in 2013. The fourth quarter is a seasonally cash generative period and this would indicate net debt levels by year end in the region of €140m after taking account of the acquisitions of Pactiv Insulation (North America) and PAL (UAE). These insulation board businesses were separately acquired in October for a combined consideration of €77m.The relative optimism that prevailed earlier in the year appears to have waned in recent months, particularly in Europe. Whilst our business continues to perform solidly, we nonetheless are mindful of what are currently more tempered 2015 economic forecasts, and remain focused on driving the Kingspan proposition, whatever the macro climate.

The fourth quarter of 2013 was particularly strong for the Group. Notwithstanding that, and with this seasonally important and often variable period to come, we expect to deliver a full-year trading profit in the region of €144m (+17% versus 2013).

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBGUGBGSR
Date   Source Headline
27th Feb 20185:03 pmRNSDirector/PDMR Shareholding
27th Feb 20189:53 amRNSHolding(s) in Company
26th Feb 20184:55 pmRNSDirector/PDMR Shareholding
23rd Feb 20187:00 amRNSFinal Results
22nd Feb 20182:58 pmRNSDirectorate Change
20th Feb 20182:33 pmRNSHolding(s) in Company
2nd Jan 201810:30 amRNSBlock listing Interim Review
2nd Jan 201810:00 amRNSTotal Voting Rights
15th Dec 20172:02 pmRNSAcquisition
15th Dec 20172:00 pmRNSInvestment Update
4th Dec 20179:31 amRNSTotal Voting Rights
13th Nov 20175:13 pmRNSReplacement - Director/PDMR Shareholding
13th Nov 20177:00 amRNSTrading Update
13th Oct 20172:39 pmRNSDirector/PDMR Shareholding
10th Oct 20179:52 amRNSHolding(s) in Company
2nd Oct 20174:37 pmRNSDirector/PDMR Shareholding
2nd Oct 20174:31 pmRNSTotal Voting Rights
29th Sep 201710:27 amRNSDirector/PDMR Shareholding
27th Sep 20172:46 pmRNSHolding(s) in Company
27th Sep 20172:46 pmRNSHolding(s) in Company
27th Sep 20177:00 amRNSAcquisition
15th Sep 201710:04 amRNSHolding(s) in Company
12th Sep 20174:55 pmRNSDirector/PDMR Shareholding
1st Sep 20175:47 pmRNSTotal Voting Rights
29th Aug 20177:00 amRNSHolding(s) in Company
23rd Aug 20175:17 pmRNSHolding(s) in Company
18th Aug 20177:00 amRNSHalf-year Report
3rd Jul 20174:15 pmRNSBlock listing Interim Review
3rd Jul 20174:09 pmRNSTotal Voting Rights
28th Jun 20173:54 pmRNSHolding(s) in Company
26th Jun 201712:24 pmRNSCompletion of EUR500m Revolving Credit Facility
13th Jun 20179:40 amRNSHolding(s) in Company
7th Jun 20175:37 pmRNSDirector/PDMR Shareholding
2nd Jun 201712:05 pmRNSHolding(s) in Company
1st Jun 20179:36 amRNSTotal Voting Rights
12th May 20172:25 pmRNSHolding(s) in Company
8th May 201710:16 amRNSDirector/PDMR Shareholding
2nd May 20172:07 pmRNSBroker Appointment
2nd May 20179:47 amRNSTotal Voting Rights
28th Apr 20172:36 pmRNSHolding(s) in Company
27th Apr 201711:36 amRNSResult of AGM
27th Apr 20177:00 amRNSTrading Statement
13th Apr 201710:49 amRNSHolding(s) in Company
3rd Apr 20179:53 amRNSTotal Voting Rights
30th Mar 201711:03 amRNSDirector/PDMR Shareholding
30th Mar 20177:00 amRNSHolding(s) in Company
24th Mar 201712:53 pmRNSHolding(s) in Company
22nd Mar 20175:01 pmRNSHolding(s) in Company
21st Mar 201710:04 amRNSDirector/PDMR Shareholding
20th Mar 201712:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.